[1] SINCLAIR A, SAEEDI P, KAUNDAL A, et al. Diabetes and global ageing among 65-99-year-old adults: Findings from the International Diabetes Federation Diabetes Atlas, 9(th) edition[J]. Diabetes Res Clin Pract, 2020, 162: 108078. [2] KOSKA J, SAREMI A, HOWELL S, et al. Advanced glycation end products, oxidation products, and incident cardiovascular events in patients with type 2 diabetes[J]. Diabetes Care, 2018, 41(3): 570-576. [3] KAWAMURA T, UMEMURA T, HOTTA N. Cognitive impairment in diabetic patients: can diabetic control prevent cognitive decline?[J]. J Diabetes Investig, 2012, 3(5): 413-423. [4] KILPATRICK E S.The rise and fall of HbA(1c) as a risk marker for diabetes complications[J]. Diabetologia, 2012, 55(8): 2089-2091. [5] 王凤.中文版罗兰通用痴呆症量表的信效度检验及其与MMSE测试性能的对比研究[D]. 湖州师范学院, 2020. [6] Standards of medical care in diabetes--2013[J]. Diabetes Care, 2013, 36 (Suppl 1): S11-S66. [7] 樊垚, 王强, 唐吉宏, 等.老年2型糖尿病病人心血管病死亡相关外周血全基因组DNA甲基化的研究[J]. 实用老年医学, 2022, 36(5): 468-472. [8] ORSI E, SOLINI A, BONORA E, et al. Haemoglobin A1c variability is a strong, independent predictor of all-cause mortality in patients with type 2 diabetes[J]. Diabetes Obes Metab, 2018, 20(8): 1885-1893. [9] 刘振宇, 魏云鹏, 王江敏, 等.2019年北京市海淀区居民身体体质指数与高尿酸血症关联强度的剂量-反应关系分析[J]. 中国卫生统计, 2023, 40(2): 259-263. [10] XIA W, LUO Y, CHEN Y C, et al. Glucose fluctuations are linked to disrupted brain functional architecture and cognitive impairment[J]. J Alzheimers Dis, 2020, 74(2): 603-613. [11] ZHENG B, SU B, PRICE G, et al. Glycemic control, diabetic complications, and risk of dementia in patients with diabetes: results from a large U.K. cohort study[J]. Diabetes Care, 2021, 44(7): 1556-1563. [12] CERIELLO A, MONNIER L, OWENS D.Glycaemic variability in diabetes: clinical and therapeutic implications[J]. Lancet Diabetes Endocrinol, 2019, 7(3): 221-230. [13] 中华医学会内分泌学分会.糖尿病患者血糖波动管理专家共识[J]. 中华内分泌代谢杂志, 2017, 33(8): 633-636. [14] MO Y, ZHOU J, MA X, et al. Haemoglobin A1c variability as an independent correlate of atherosclerosis and cardiovascular disease in Chinese type 2 diabetes[J]. Diab Vasc Dis Res, 2018, 15(5): 402-408. [15] 胡佳琪, 徐慧君, 刘超, 等.HbA 1C变异性的影响因素及其对2型糖尿病视网膜病变的作用[J]. 中华内分泌代谢杂志, 2020, 36(5): 381-386. [16] 黄郁玲, 李鸿娟, 晁婧媛, 等.中高海拔地区汉族高龄老年人轻度认知功能障碍与血管相关因素[J]. 中国老年学杂志, 2018, 38(14): 3416-3419. [17] 吴林秀, 覃小双.2型糖尿病相关认知障碍发生机制的研究进展[J]. 糖尿病新世界, 2018, 21(15): 194-196. [18] JIA L, DU Y, CHU L, et al. Prevalence, risk factors, and management of dementia and mild cognitive impairment in adults aged 60 years or older in China: a cross-sectional study[J]. Lancet Public Health, 2020, 5(12): e661-e671. [19] 中华医学会内分泌学分会.糖尿病患者认知功能障碍专家共识[J]. 中华糖尿病杂志, 2021, 13(7): 678-694. [20] 陈羽, 吕洋.肌肉减少症与认知障碍的相关性研究进展[J]. 实用老年医学, 2020, 34(2): 111-116. [21] 孙彬彬, 张媛媛, 贾建军.老年认知功能障碍可控危险因素的研究进展[J]. 中华老年多器官疾病杂志, 2022, 21(12): 888-891. |